Published in Medical Letter on the CDC and FDA, August 1st, 2010
"The objective of this study was to evaluate the effect of RV5 on acute gastroenteritis (AGE) seen in a primary practice. In July 2004, surveillance was initiated among children who were younger than 5 years and seen in a large pediatric practice in New Orleans for those who presented AGE,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA